Evidence base for new vaccine introduction in Latin America and the Caribbean

Vaccine

Volumn 31, Issue SUPPL.3, 2013, Pages

  Andrus, Jon K ^a   Walker, Damian G ^b  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE; VACCINE; WART VIRUS VACCINE;

CENTRAL AMERICA; COST EFFECTIVENESS ANALYSIS; EDITORIAL; FINANCIAL MANAGEMENT; HEALTH CARE UTILIZATION; HUMAN; IMMUNIZATION; MEDICAL DECISION MAKING; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA;

CARIBBEAN REGION; DECISION MAKING; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; LATIN AMERICA; PAN AMERICAN HEALTH ORGANIZATION; PUBLIC HEALTH; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; REGIONAL HEALTH PLANNING; VACCINES;

EID: 84879205625     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.05.074     Document Type: Editorial

References (27)

1. Sachs J. UN Millennium Project. United Nations Development Programme. Investing in development: a practical plan to achieve the Millennium Development Goals. Overview 2005, Earthscan, London, Sterling, VA.
2. Rotavirus vaccines. Wkly Epidemiol Rec [Practice Guideline] 2007, 82(August (32)):285-295.
3. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 2007, 82(March (12)):93-104.
4. World Health Organization WHO position paper on Haemophilus influenzae type b conjugate vaccines. Bull World Health Org 2006, 81(47):445-452.
5. World Health Organization Meningococcal vaccines: WHO position paper. Bull World Health Org 2011, 86(47):521-540.
6. World Health Organization Human papillomavirus vaccines: WHO position paper. Bull World Health Org 2009, 84(15):117-132.
7. Andrus J.K., Toscano C.M., Lewis M., Oliveira L., Ropero A.M., Davila M., et al. A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative. Public Health Rep 2007, 122(November-December (6)):811-816.
8. Jauregui B., Sinha A., Clark A.D., Bolanos B.M., Resch S., Toscano C.M., et al. Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative. Vaccine 2011, 29(January (5)):1099-1106.
9. Clark A., Jauregui B., Griffiths U., Janusz C., Bolaños-Sierra B., Hajjeh R., et al. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination. Vaccine 2013, 31(S(3)):C19-C29.
10. Castañeda-Orjuela C., Romero M., Arce P., Resch S., Janusz C.B., Toscano C., et al. Using standardized tools to improve immunization costing data for program planning: the cost of the Colombian Expanded Program on Immunization. Vaccine 2013, 31(S(3)):C72-C79.
11. Toscano C.M., Jauregui B., Janusz C.B., Sinha A., Clark A.D., Sanderson C., et al. Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac Experience. Vaccine 2013, 31(S(3)):C12-C18.
12. Bahia L., Toscano C.M., Takemoto M.L.S., Vianna Araujo D. Systematic review pof pneumococcal disease costs and productivity loss studies in Latin America and the Caribbean. Vaccine 2013, 31(S(3)):C33-C44.
13. Takemoto M.L.S., Bahia L., Toscano C.M., Vianna Araujo D. Systematic review of studies on rotavirus disease cost-of-illness and productivity loss in Latin America and the Caribbean. Vaccine 2013, 31(S(3)):C45-C57.
14. Sartori A.M.C., Novaes C.G., de Soárez P.C., Toscano C.M., Novaes H.M.D. Estimating health service utilization for treatment of pneumococcal disease: the case of Brazil. Vaccine 2013, 31(S(3)):C63-C71.
15. Alvis-Guzmán N., Orozco-Africano J., Paternina-Caicedo A.J., Coronell-Rodríguez W., Alvis-Estrada L., Jervis-Jálabe D., et al. Treatment costs of diarrheal disease and all-cause pneumonia among children under-5 years of age in Colombia. Vaccine 2013, 31(S(3)):C58-C62.
16. De la Hoz-Restrepo F., Castañeda-Orjuela C., Paternina-Caicedo A., Alvis-Guzman N. Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines. Vaccine 2013, 31(S(3)):C80-C87.
17. Hyde T., Andrus J.K., Dietz V.J. Critical issues in implementing a national integrated all-vaccine preventable disease surveillance system. Vaccine 2013, 31(S(3)):C94-C98.
18. Toscano C.M., Vijayaraghavan M., Salazar-Bolaños H.M., Bolaños-Acuña H.M., Ruiz-González A.I., Barrantes-Solis T., et al. Cost analysis of an integrated all vaccine-preventable disease surveillance system in Costa Rica. Vaccine 2013, 31(S(3)):C88-C93.
19. de Oliveira L., Giglio N., Ciapponi A., García Martí S., Kuperman M., Sanwogou J.N., et al. Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries. Vaccine 2013, 31(S(3)):C99-C108.
20. Picón T., Alonso L., García Gabarro G., Speranza N., Casas M., Arrieta F., et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: an evaluation using existing data. Vaccine 2013, 31(S(3)):C109-C113.
21. De Oliveira L., Toscano C.M., Sanwogou J.N., Ruiz Matus R., Tambini, Roses-Periago M., et al. Systematic documentation of new vaccine introduction in selected countries of the Latin American Region. Vaccine 2013, 31(S(3)):C114-C122.
22. Pan American Health Organization Introduction and implementation of new vaccines: field guide. Publicación científica y técnica No 632 2010, Pan American Health Organization, Washington, DC.
23. de Quadros C. Historical perspectives on new vaccine introduction in Low and Middle-income countries. Vaccine 2013, [in press].
24. Glassman A. Building instituions for better public spending on vaccination. Vaccine 2013, 31(S(3)):C10-C11.
25. Hinman A. Perspectives on sustainable vaccine introduction. Vaccine 2013, 31(S(3)):C8-C9.
26. Sinha A., Augustovski F., Alcaraz A., García Marti S. Perspectives on the challenge of Streptococcus pneumoniae disease burden estimation for national policymakers in Latin America and the Caribbean: from theory to practice. Vaccine 2013, 31(S(3)):C30-C32.
27. Whitney C., Parashar U. Evidence-based introduction of rotavirus and pneumococcal conjugate vaccines: experiences from the US. Vaccine 2013, 31(S(3)):C6-C7.